135 related articles for article (PubMed ID: 2191770)
1. Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens.
Fox TR; Schumann AM; Watanabe PG; Yano BL; Maher VM; McCormick JJ
Cancer Res; 1990 Jul; 50(13):4014-9. PubMed ID: 2191770
[TBL] [Abstract][Full Text] [Related]
2. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
3. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
Wang Y; Wang Y; Stoner G; You M
Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
[TBL] [Abstract][Full Text] [Related]
4. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
5. ras gene activation in rat tumors induced by benzidine congeners and derived dyes.
Reynolds SH; Patterson RM; Mennear JH; Maronpot RR; Anderson MW
Cancer Res; 1990 Jan; 50(2):266-72. PubMed ID: 2403837
[TBL] [Abstract][Full Text] [Related]
6. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.
Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Ledwith BJ; van Zwieten MJ; Bradley MO; Nichols WW
Cancer Res; 1992 Jun; 52(12):3347-52. PubMed ID: 1596892
[TBL] [Abstract][Full Text] [Related]
7. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
8. N-ras mutation in ultraviolet radiation-induced murine skin cancers.
Pierceall WE; Kripke ML; Ananthaswamy HN
Cancer Res; 1992 Jul; 52(14):3946-51. PubMed ID: 1617670
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
Vorce RL; Goodman JI
Mol Toxicol; 1989; 2(2):99-116. PubMed ID: 2702305
[TBL] [Abstract][Full Text] [Related]
10. Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator.
Hegi ME; Fox TR; Belinsky SA; Devereux TR; Anderson MW
Carcinogenesis; 1993 Jan; 14(1):145-9. PubMed ID: 8425263
[TBL] [Abstract][Full Text] [Related]
11. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
Vorce RL; Goodman JI
J Toxicol Environ Health; 1991 Nov; 34(3):367-84. PubMed ID: 1658350
[TBL] [Abstract][Full Text] [Related]
12. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2.
Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP
Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458
[TBL] [Abstract][Full Text] [Related]
13. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
15. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model.
Corominas M; Leon J; Kamino H; Cruz-Alvarez M; Novick SC; Pellicer A
Oncogene; 1991 Apr; 6(4):645-51. PubMed ID: 1840681
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies.
Duddy SK; Gorospe SM; Bleavins MR; de la Iglesia FA
Toxicol Appl Pharmacol; 1999 Oct; 160(2):133-40. PubMed ID: 10527912
[TBL] [Abstract][Full Text] [Related]
17. Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats.
Watatani M; Perantoni AO; Reed CD; Enomoto T; Wenk ML; Rice JM
Cancer Res; 1989 Mar; 49(5):1103-9. PubMed ID: 2645046
[TBL] [Abstract][Full Text] [Related]
18. Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis.
Dragani TA; Manenti G; Colombo BM; Falvella FS; Gariboldi M; Pierotti MA; Della Porta G
Oncogene; 1991 Feb; 6(2):333-8. PubMed ID: 2000226
[TBL] [Abstract][Full Text] [Related]
19. DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene.
Culp SJ; Warbritton AR; Smith BA; Li EE; Beland FA
Carcinogenesis; 2000 Jul; 21(7):1433-40. PubMed ID: 10874023
[TBL] [Abstract][Full Text] [Related]
20. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
Kumar R; Medina D; Sukumar S
Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
